Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 2,550 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
clofazimine
Identification of novel mutations associated with clofazimine resistance in Mycobacterium abscessus
Chen, Y.; Chen, J.; Zhang, S.; Zhang, W.; Zhang, W.; Zhu, M.; Zhang, Y.
biorxiv
. 2018-03-04. Preprint
Source:biorxiv
PPRID:
10.1101/276022v1
doi:10.1128/aac.00544-18
Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract.
A Mathur, K Venkatesan, V P Bharadwaj, G Ramu
Indian J Lepr
. 1985 Jan-Mar.57(1):146-8 Print
Source:PubMed
PMID:
3839813
doi:
Clofazimine binding studies with deoxyribonucleic acid.
N E Morrison, G M Marley
Int J Lepr Other Mycobact Dis
. 1976 Oct-Dec.44(4):475-81 Print
Source:PubMed
PMID:
798729
doi:
Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients.
P F Cariello, E J Kwak, R C Abdel-Massih, F P Silveira
Transpl Infect Dis
. Feb, 2015.17(1):111-8 Print-Electronic
Source:PubMed
PMID:
25620390
doi:10.1111/tid.12340
A case of clofazimine enteropathy.
A Hameed, F X Beach, R H Kennedy, R E Barry
Int J Clin Pract
. Sep, 1998.52(6):439-40 Print
Source:PubMed
PMID:
9894387
doi:
Impacts of clofazimine on the treatment outcomes of drug-resistant tuberculosis.
Ming-Gui Wang, Xiang-Min Liu, Shou-Quan Wu, Jian-Qing He
Microbes Infect
. 2023 Jan-Feb.25(1-2):105020 Print-Electronic
Source:PubMed
PMID:
35792202
doi:10.1016/j.micinf.2022.105020
[Tissue distribution and deposition of clofazimine in mice following oral administration of isoniazid].
Yu Lu, Mei-Qin Zheng, Bin Wang, Wei-Jie Zhao, Lei Fu, Peng Li, Bo-Wen Liang, Nai-Hui Chu
Zhonghua Jie He He Hu Xi Za Zhi
. Sep, 2009.32(9):694-7 Print
Source:PubMed
PMID:
20079285
doi:
Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
H Saito, K Sato
Tubercle
. Sep, 1989.70(3):201-5 Print
Source:PubMed
PMID:
2559522
doi:10.1016/0041-3879(89)90051-2
Clofazimine: new products. Major antileprous drug.
No authors listed
Prescrire Int
. Apr, 1999.8(40):44-6 Print
Source:PubMed
PMID:
10848059
doi:
Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with Mycobacterium abscessus Pulmonary Disease.
Masashi Ito, Fumiya Watanabe, Koji Furuuchi, Keiji Fujiwara, Tatsuya Kodama, Takashi Ohe, Yoshiaki Tanaka, Takashi Yoshiyama, Ken Ohta, Kozo Morimoto
Intern Med
. Nov 21, 2024.: Print-Electronic
Source:PubMed
PMID:
39566985
doi:10.2169/internalmedicine.4498-24
0
Previous
Next